Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States ; day:10 ; month:4 ; year:2024 ; pages:1-13
Aids and behavior ; (10.4.2024), 1-13
- Creator
-
Erguera, Xavier A.
Koester, Kimberly A.
Diaz Tsuzuki, Manami
Dance, Kaylin V.
Flores, Rey
Kerman, Jared
McNulty, Moira C.
Colasanti, Jonathan A.
Collins, Lauren F.
Montgomery, Elizabeth T.
Johnson, Mallory O.
Sauceda, John A.
Christopoulos, Katerina A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10461-024-04315-0
- URN
-
urn:nbn:de:101:1-2406250907021.918162573207
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Erguera, Xavier A.
- Koester, Kimberly A.
- Diaz Tsuzuki, Manami
- Dance, Kaylin V.
- Flores, Rey
- Kerman, Jared
- McNulty, Moira C.
- Colasanti, Jonathan A.
- Collins, Lauren F.
- Montgomery, Elizabeth T.
- Johnson, Mallory O.
- Sauceda, John A.
- Christopoulos, Katerina A.
- SpringerLink (Online service)
Other Objects (12)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Establishing healthy longevity clinics in publicly funded hospitals
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Perceptions of and preferences for federally-funded family planning clinics
RYAn
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Establishing healthy longevity clinics in publicly funded hospitals
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Perceptions of and preferences for federally-funded family planning clinics
RYAn
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Establishing healthy longevity clinics in publicly funded hospitals
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Perceptions of and preferences for federally-funded family planning clinics
RYAn
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study